Press "Enter" to skip to content

Merck Throws Its Hat Into The Ring With Keytruda For Treating Subset Of Lung Cancer Patients – Seeking Alpha

admin 0

Merck Throws Its Hat Into The Ring With Keytruda For Treating Subset Of Lung Cancer Patients  Seeking Alpha

Merck Announced FDA approval for Keytruda as a third-line therapy for patients with SCLC. SCLC accounts for about 10% to 15% of the entire lung cancer …

“lung cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *